2024-03-29T02:02:28Zhttp://digital.csic.es/dspace-oai/requestoai:digital.csic.es:10261/2235372022-08-31T14:55:05Zcom_10261_3284com_10261_1col_10261_3285
A spotlight on cancer researchers in Spain: new paradigms and disruptive ideas
Ramón y Cajal, S.
Sancho, P.
Soucek, L.
Peinado, H.
Abad, M.
Valiente, M.
Efeyan, A.
Pardo, J.
Quesada, V.
Jimeno, J.
Duque, P. M.
Antón, A.
Varela, Ignacio
Schuhmacher, A. J.
Universidad de Zaragoza
Telefónica
Ibercaja
Fundación Fero
Cancer research
Liquid biopsy
Paradigms
Clonal cooperation
Over the last years, there have been relevant advances in cancer research and in treatment based on specifc genetic alterations improving survival in some tumors. Nevertheless, progress is still dismal in most carcinomas when are disseminated with metastasis; the survival is less than 30% in most cases. Then, we need to move forward looking for new paradigms which may explain the complex mechanisms involved in carcinogenesis and in new treatment approaches.
We thank to the University of Zaragoza for the opportunity to organize this meeting and to Telefonica, Ibercaja and the Fero Foundation for its support.
2020-11-24T09:00:03Z
2020-11-24T09:00:03Z
2020
2020-11-24T09:00:03Z
editorial
http://purl.org/coar/resource_type/c_b239
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22: 798-801 (2020)
1699-048X
http://hdl.handle.net/10261/223537
10.1007/s12094-019-02199-4
1699-3055
http://dx.doi.org/10.13039/501100007041
http://dx.doi.org/10.1007/s12094-019-02199-4
Sí
none
Springer